News and Events
CGT Global Exhibiting at ASH 2019
Join StemExpress at ASH 2019 Mark your calendar for the world’s most comprehensive hematology event of the year, the 61st ASH 2019 Annual Meeting and Exposition in sunny Orlando. The meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with…
For More InformationCGT Global Exhibiting at CAR-TCR Summit 2019
ABOUT THE EVENT Join StemExpress at CAR-TCR Summit 2019 There is growing excitement and momentum in the field of cellular therapy fuelled by two approved CAR-T products moving full steam ahead to global approval. However, despite these amazing achievements, both drugs are currently struggling on the market and have only treated a handful of patients…
For More InformationCGT Global is exhibiting at ISSCR 2019!
ABOUT THE EVENT The World’s Largest Stem Cell-focused Meeting With more than 3,500 attendees, speakers, exhibitors, sponsors, and media, the meeting brings together everyone from senior scientists to trainees to discover, share, and network with leading innovators in the stem cell community. Through our scientific programming and networking opportunities, we provide inspiration and insight to…
For More InformationCGT Global is exhibiting at World Preclinical Congress!
ABOUT THE EVENT The 18th Annual World Preclinical Congress is a key scientific and networking event yielding new partnerships that accelerate preclinical research and translation across all therapeutic areas. It offers a unique opportunity for leading scientists and executives from industry and academia as well as technology providers to come together and exchange expertise and opinions in the…
For More InformationCGT Global Announces Release of New Frozen Leukopak
[vc_row][vc_column][vc_separator][vc_column_text]Folsom, Calif. – To continue to provide new products and services to further advance medical research around the world, StemExpress announces the release of NEW Frozen Leukopak. StemExpress Leukopaks, collected fresh and then immediately frozen, provide an enriched source of peripheral blood mononuclear cells (PBMCs) that can be used in a variety of medical research…
For More InformationCGT Global is exhibiting at BIO 2019
ABOUT THE EVENT Join us in Philadelphia, PA, June 3-6, 2019 as more than 16,000 attendees from around the globe gather for unparalleled partnering, education, networking, and to see all that tri-state area has to offer. The region’s vast array of leading universities and research institutions fosters a collaborative environment. The key benefits of attending…
For More InformationCGT Global is exhibiting at International Society Cell & Gene Therapy (ISCT)
ABOUT THE EVENT ISCT is a global society of clinicians, regulators, technologists, and industry partners with a shared vision to translate cellular therapy into safe and effective therapies to improve patients’ lives. ISCT Members gain access to an influential global community of peers, experts, and organizations invested in cell therapy. ISCT offers a unique collaboration…
For More InformationCGT Global is exhibiting at AAI Immunology 2019
ABOUT THE EVENT Join us for IMMUNOLOGY 2019™ in San Diego, California at the San Diego Convention Center. AAI hosts the world’s largest annual all-immunology meeting, bringing together scientists at every career stage to discuss their cutting-edge research. International leaders in immunology and talented trainees alike will be coming to learn what innovations and biomedical…
For More InformationCGT Global Announces New Distribution Partnerships
STEMEXPRESS EXPANDS INTO ASIA PACIFIC To continue meeting the needs of clients around the world, StemExpress announces the expansion of its existing distribution network in the Asia Pacific region, adding to their current partnerships with companies in North America, Europe, and North Africa. StemExpress now includes distribution partnerships with ATCG Limited (Hong Kong), Kim &…
For More InformationCGT Global is exhibiting at Car-T Congress USA
ABOUT THE EVENT CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite, the race is on to lead the commercialization of safe, efficacious and accessible CAR-T therapy. The fourth annual CAR-T congress USA…
For More Information